Get the Weekly Intelligence Brief — top committee picks every Sunday.

LQDA vs RPRX

Liquidia Corporation vs Royalty Pharma plc — AI-powered side-by-side comparison
LQDA
Liquidia Corporation
68
Buy
VS
RPRX
Royalty Pharma plc
56
Watch
MetricLQDARPRX
AI Score 68 56
Price $88.09 $57.79
P/E Ratio 368.26× 23.98×
ROE -154.0% 11.9%
Revenue Growth YoY
Gross Margin 91.8% 89.4%
Debt / Equity 1.70× 1.31×
Dividend Yield 0.0% 1.6%
RSI (14) 55.0 49.6
Beta 0.572 0.425
Expected Upside

AI Committee View

Current Innellis committee reasoning for LQDA versus RPRX.
LQDA leads by 12 points.

LQDA scores 68/100 (Buy) versus RPRX at 56/100 (Watch).

LQDA Committee View
67% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 46.8% shows genuine earnings power backing the valuation — Value
  • Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • P/E of 362.9 is expensive by classic value standards — Value
  • Price-to-book of 12.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
RPRX Committee View
60% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 40.9 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • P/E of 40.9 is expensive by classic value standards — Value
  • EPS declining -15.9% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LQDA Full Analysis RPRX Full Analysis